Introduction {#s1}
============

Remodeling of the uterine spiral arteries (SpA) into low resistance, high capacity vessel begins as extravillous trophoblasts (EVT) invade the decidua during first trimester and is essential for successful pregnancy (Kam et al., [@B16]). When EVT "plugs" are lost during early second trimester, maternal blood flows through the modified vessels to deliver nutrients and oxygen to support fetal growth and development (Pijnenborg et al., [@B25]). EVT continue to invade into the myometrium and remodel the SpA until mid-second trimester (Hamilton and Boyd, [@B13]; Pijnenborg et al., [@B27]; Blackburn et al., [@B5]; American Diabetes Association, [@B1]). The initial steps of uterine spiral artery remodeling consists of vessel dilatation, vascular smooth muscle cells (VSMC) separation, endothelial cell swelling, EVT infiltration, and fibrinoid deposition (Pijnenborg et al., [@B26]). VSMC migrate or undergo apoptosis and are replaced by fibriniod material, in which EVT cells embed. Recently Bulmer et al. showed that during SpA remodeling, VSMC migrate outside of the artery, and this phenomenon is enhanced in the presence of EVT (Bulmer et al., [@B6]). While the mechanisms by which EVTs remodel SpA remain to be fully elucidated, available data are consistent with the hypothesis that EVT directly interact with VSMC of the uterine spiral arteries. We propose that the releases of nanoparticles (i.e., exosomes) that contain specific effector molecules (e.g., proteins and miRNAs) are released from EVT and affect the loss of VSMC.

Exosomes (30--100 nm) are nanovesicles released when late endosomes fuse with the cell membrane (Thery, [@B33]; Salomon et al., [@B28]). Exosomes interact with target cells via multiple pathways including: by directly activating target cell membrane receptors; by modifying the extracellular *milieu* of the target cell; and by fusing with the cell membrane and releasing the molecular cargo into the target cell (Pegtel et al., [@B24]). Their molecular cargo is: cell-specific (Kobayashi et al., [@B19]); regulated by tissue physiology and cellular function; and fundamental to their bioactivity.

Exosomes are identified in cell-conditioned media and body fluids indicate that they can be released from different types of cells (Vlassov et al., [@B34]). Recently, the role of exosomes isolated from placental cells (Salomon et al., [@B28],[@B29]) and other cell types (Chen et al., [@B9]; Lee et al., [@B21]; Yoon et al., [@B36]) on cell migration has been established. Exosomes released from first trimester placental mesenchymal stem cells (pMSC) increase endothelial cell migration and vascular tube formation *in vitro* (Salomon et al., [@B28]). Similarly, cytotrophoblast-derived exosomes increase EVT migration *in vitro* (Salomon et al., [@B29]).

Consistent with the proposal that exosomal signaling regulates cell migration and invasion, proteins associated with actin cytoskeleton, growth hormone, and VEGF signaling have been identified within exosomes. The effect of EVT-derived exosomes on VSMC migration, however, remains to be established. We, therefore, hypothesize that exosomes released by EVT act paracellularly to promote VSMC migration and thus contributing to SpA remodeling. The aims of this study were: (1) to compare the exosome release and exosomal protein composition derived from EVT cell lines from different origin (JEG-3 and HTR-8/SVneo); and (2) to establish the effect of exosomes from both JEG-3 and HTR-8/SVneo cells on human VSMC migration.

Numerous human trophoblastic cell lines have been established, which basically originated from normal tissues or from pathological tissues. JEG3 is a choriocarcinoma cell line cloned from primary choriocarcinoma (Kohler and Bridson, [@B20]), and HTR8/SVneo is a transformed extravillous trophoblast cell line established by immortalizing primary EVT cells via transfection with simian virus 40 large T antigen (SV40) (Graham et al., [@B12]); both cell lines are frequently used as models of physiologically invasive extravillous trophoblast. EVT invasion into the myometrium is a critical process for remodeling the uterine spiral artery (in this stage EVT interact with VSMC), however, the invasiveness capacity between these two cells lines are different. HTR-8/SVneo have significantly higher invasion capacity than JEG-3 (Suman and Gupta, [@B32]). Moreover, differences between these two cells lines are not just in the invasion capacity, but also in their miRNA profiles (Morales-Prieto et al., [@B23]) as well as their protease (e.g., metalloproteases-9) expressions (Suman and Gupta, [@B32]), however, functional differences between exosome vesicles derived from JEG-3 and HTR-8/SVneo remain to be established. Previously, these cells lines have been validated and used routinely as models of EVT function (Suman and Gupta, [@B32]; Weber et al., [@B35]).

The aim of this study was to test the hypotheses that: (1) exosomes from EVT act paracellularly to promote VSMC migration; and (2) The release, protein content and bioactivity of exosomes is cell origin-dependent (i.e., EVT cell lines from choriocarcinoma and chorionic villi). The effects of exosomes isolated from the EVT-like cell lines, JEG-3 and HTR-8/SVneo cells on VSMC migration were assessed.

The data obtained are consistent with the hypothesis that the function of EVT-derived exosomes is cell origin specific and showed differences in the release, content and effects on VSMC migration. EVT may communicate with VSMC during SpA remodeling, stimulating their migration through these specific nanovesicles (i.e., exosomes).

Materials and methods {#s2}
=====================

Materials
---------

Medium RPMI 1640, Medium 231, Smooth Muscle Growth Supplement (SMGS), glutamine, antibiotics, HEPES, and phosphate buffered saline (PBS) were obtained from Life Technologies Corporation (Mulgrave, Victoria, Australia). CD63 ELISA kits were obtained from SBI (ExoELISA™, System Biosciences, Mountain View, CA).

Cell culture
------------

All experimental procedures were conducted within an ISO17025 accredited (National Association of Testing Authorities, Australia) research facility. All data were recorded within a 21 Code of Federal Regulation (CFR) part 11 compliant electronic laboratory notebook (Irisnote, Redwood City, CA, USA). JEG-3 human choriocarcinoma cell line was purchased from the European Collection of Cell Cultures (Porton Down, Salisbury, UK). The HTR-8/SVneo cell line was kindly donated by Dr. Charles H. Graham (Queen\'s University, Ontario, Canada). HTR-8/SVneo was established by the transfection of trophoblast cells isolated from first trimester villous explants, with a gene encoding simian virus 40 large T antigen to immortalize them (Graham et al., [@B12]). JEG-3 and HTR-8/SVneo cells were maintained in phenol red-free RPMI 1640 medium supplemented with 10% heat-inactivated fetal bovine serum, 1% non-essential amino acids, 1 mM sodium pyruvate and 100 U/mL penicillin, and 100 mg/mL streptomycin. Cultures were maintained at 37°C and humidified under an atmosphere of 5% CO~2~-balanced N~2~ to obtain 8% O~2~ (pO~2~ \~54 mmHg) in an automated PROOX 110-scaled hypoxia chamber (BioSphericsacona, NY, USA). Cells were subcultured with dissociation media, TrypLE™ Express (Life technologies, USA) and cellular viability was determined by Trypan Blue exclusion and Countess® Automated cell counter (Life Technologies, USA).

Human Vascular Smooth Muscle cells (hVSMC) were purchased from LONZA (Lonza Group Ltd.). VSMC were cultured in 231 media (Life Technologies Corporation) supplemented with SMGS, 100 U/ml penicillin, and 100 μg/ml streptomycin, at 37°C and humidified under an atmosphere of 5% CO~2~-balanced N~2~ to obtain 8% O~2~ (pO~2~ \~54 mmHg) in an automated PROOX 110-scaled hypoxia chamber (BioSpherics™, Lacona, NY, USA).

The *in vitro* cell migration rates of JEG-3 and HTR-8/SVneo we established using real-time cell imaging system (IncuCyte™ live-cell ESSEN BioScience Inc., Ann Arbor, MI, USA). Using a scratch assay format, cell were imaged every 3 h to monitor cell migration as previously described (Salomon et al., [@B29]).

Exosome isolation
-----------------

Exosomes were isolated from cell-free JEG-3 and HTR-8/SVneo- conditioned media as previously described (Salomon et al., [@B28]; Kobayashi et al., [@B19]). In brief, cell-conditioned media was centrifuged at 300 × g for 15 min, 2000 × g for 30 min, and 12,000 × g for 45 min to remove whole cells and debris. The resultant supernatant were passed through a 0.22 μm filter sterilize Steritop™ (Millipore, Billerica, MA, USA) and then centrifuged at 120,000 × g for 70 min (Thermo Fisher Scientific Ins., Asheville, NC, USA, Sorvall, SureSpin™ 630/36, fixed angle rotor). The pellet was resuspended in PBS, washed and re-centrifuged (120,000 × g, 75 min). The pellet was resuspended in PBS, layered on a cushion of 30% (w/v) sucrose and centrifuged at 110,000 g for 75 min. The fraction containing exosomes \[\~3.5 ml, 1.127 density using OPTi digital refractometer (Bellingham^+^Stanley Inc., Lawrenceville, GA, USA)\] was recovered using a Pulse-Free Flow Peristaltic Pump with a flow rate range of 1 ml per min (GILSON Miniplus® model 3) and Fraction Collector (GILSON FC 203B model) and diluted in PBS, and then ultracentrifuged at 110,000 × g of 70 min. Recovered exosomes were resuspended in 50 μl PBS and their protein contents were determined using the Bradford assay (Bio-Rad DC). Exosome samples (5 μl) were prepared by adding RIPA buffer (50 mM Tris, 1% Triton × 100, 0.1% SDS, 0.5% DOC, 1 mM EDTA, 150 mM NaCl, protease inhibitor) directly to exosomes suspended in PBS and sonicated at 37°C for 15 s three times to disrupt exosomes and solubilise the proteins. Bovine serum albumin (BSA) diluted in RIPA buffer and PBS mixture (1:1) were prepared as protein standards (0, 200, 400, 600, 800, 1000, 1500 μg/mL). Standards and samples (exosomes) were transferred to 96-well plates and procedures outlined by the manufacture were followed. In brief, alkaline copper tartrate solution (Bio-Rab Laboratories, Hercules, CA, USA) and dilute Folin Reagent (Bio-Rab Laboratories,) were added to the samples and incubated for 15 min. The absorbance was read at 750 nm with Paradigm Detection Platform (Beckman Coulter, USA).

Nanoparticle tracking analysis (NTA)
------------------------------------

NTA measurements were performed using a NanoSight NS500 instrument (NanoSight NTA 2.3 Nanoparticle Tracking and Analysis Release Version Build 0033) following the manufacturer\'s instructions. The NanoSight NS500 instrument measured the rate of Brownian motion of nanoparticles and consists in a light scattering system that provides a reproducible platform for specific and general nanoparticle characterization (NanoSight Ltd., Amesbury, UK). Samples were processed in duplicate and diluted with PBS over a range of concentration to obtain between 10 and 100 particles per image (optimal \~50 particles × image) before the analysis with the NTA system. The samples were mixed before introducting into the chamber (temperature: 25°C and viscosity: 0.89 cP) and the camera level set to obtain an image that had sufficient contrast to clearly identify particles while minimizing background noise with video recording (camera level: 10 and capture duration: 60 s). Afterwards, the capture videos (2 videos per sample) were processed and analyzed. A combination of high shutter speed (450) and gain (250) followed by manual focusing enables optimum visualization of the maximum number of vesicles. A minimum of 200 completed tracks per video were collected in duplicate for each sample analyzed. NTA post acquisition settings were optimized and kept constant between samples (Frames Processed: 1496 of 1496, Frames per Second: 30, camera shutter: 20 ms; Calibration: 139 nm/pixel, Blur: 3 × 3; Detection Threshold: 10; Min Track Length: Auto; Min Expected Size: Auto), and each video was then analyzed to give the mean, mode, and median particle size together with an estimated number of particles. An Excel spreadsheet (Microsoft Corp., Redmond, Washington) was also automatically generated, recording the concentration at each particle size.

Transmission electron microscopy
--------------------------------

Exosome pellets (as described above, 30 μg protein) were fixed in 3% (w/v) glutaraldehyde and 2% paraformaldehyde in cacodylate buffer, pH 7.3. Exosome samples were then applied to a continuous carbon grid and negatively stained with 2% uranyl acetate. The samples were examined in an FEI Tecnai 12 transmission electron microscope (FEI™, Hillsboro, OR, USA).

Quantification of cell-derived exosome
--------------------------------------

The concentration of exosomes from EVT cells lines (JEG-3 and HTR-8/SVneo) in maternal circulation was expressed as total immunoreactive exosomal CD63 (ExoELISA™, System Biosciences, Mountain View, CA). Briefly, 10 μg of exosomal protein was immobilized in micro-titer plate wells and incubated overnight (binding step). Plates were washed three times for 5 min using a wash buffer solution and then incubated with exosome specific primary antibody (CD63) at room temperature (RT) for 1 h on a shaker. Plates were washed and incubated with secondary antibody (1:5000) at RT 1 h on a shaker. Plates were washed and incubated with Super-sensitive TMB ELISA substrate at RT for 45 min while shaking. The reaction was terminated using Stop Buffer solution. Absorbance was measured at 450 nm. The number of exosomes/ml, (ExoELISA™ kit) was obtained using an exosomal CD63 standard curve calibrated against nanoparticle tracking data (i.e., number of exosomes, NanoSight™). The coefficients of intra- and inter-assay variations were less than 8%.

Effect of exosomes on vascular smooth muscle cells (VSMC) migration
-------------------------------------------------------------------

VSMC were cultured in 231 media supplemented with 0.2% FBS-exosome free in 96-well culture plate (Corning Life Science, Tewksbury, MA, USA) according to the manufacturer\'s instructions for 18--24 h. Firstly, we analyzed the effect of cell proliferation on cell migration assay in our experimental conditions using an anti-proliferative drug Mitomycin C (SIGMA-ALDRICH). Cells were plated (1 × 10^5^ cells per well) onto 24-well plate, and after 24 h Mitomycin C (50 and 100 ng/ml) was added to the cell for 48 h. Cell proliferation was quantified (time-curve) by measuring the cell confluence using a real time imagining system IncuCyte™. Simultaneously, VSMC migration assay in the presence of Mitomycin C (50 and 100 ng/ml) for 48 h was performed.

During experiments, VSMC cells were incubated in the presence (treatment: 100 μg exosomal protein/ml) or absence (control) of exosomes for up to 48 h under 8% O~2~ (*n* = 12). The concentration used in this study was based upon exosome dose-response curves from our previously published studies (Salomon et al., [@B28],[@B29], [@B30]). Exosomes were subjected to heat inactivation (30 min at 65°C) or sonication for 30 min (sonicator bath) before the incubation on VSMC. Cell migration was assessed using a scratch assay format. A scratch was made on confluent monolayers using a 96-pin WoundMaker™ (BioScience Inc, Ann Arbor, MI, USA). Wound images were automatically acquired and registered by the IncuCyte™ software system. CellPlayer™ 96-Well Invasion Assay software was use to fully automate data collection. Data were processed and analyzed using IncuCyte™ 96-Well Cell Invasion Software Application Module. Data are presented as the Relative Wound Density (RWD, Eizen, v1.0 algorithm). RWD is a representation of the spatial cell density in the wound area relative to the spatial cell density outside of the wound area at every time point (time-curve). Migration assays were performed in the presence of Mitomycin C (100 ng/ml) to minimize any confounding effects of cell proliferation. The rate of wound closure was compared using the half-maximal stimulatory time (ST~50~) and area under the time course curve (AUC).

Exosome internalization
-----------------------

For exosome uptake analysis, the exosomes pellet (before purification using 30% sucrose cushion) isolated from JEG-3 and HTR-8/SVneo cells was resuspended in PBS and stained with PKH67 green fluorescent cell linker kit follow the manufacturer\'s instructions (Sigma-Aldrich). The staining reaction was stopped after 5 min with exosome-free FBS. Exosomes were then purified using 30% sucrose cushion as described above. Exosomes-PKH67 (100 μg/ml from JEG-3 and HTR-8/svneo cells) were incubated on VSMC for 24 h and exosome uptake was quantified using IncuCyte™ (fluorescent mode). Simultaneously, VSMC were grown in glass bottom chamber slides, and labeled exosomes (100 μg/ml) were added to subconfluent cells. After 24 h, VSMC were washed and fixed using 2% paraformaldehyde for 5 min at RT. Cells were immediately analyzed using a Zeiss fluorescence microscope (Axio Imager M1, Zeiss EC Plan-NEOFLUAR 40×/0.75, the Carl Zeiss Group, Germany) with FITC and DAPI absorbance setting.

Proteomic analysis of cytotrophoblast derived-exosomes by mass spectrometry (MS)
--------------------------------------------------------------------------------

Isolated exosomes from JEG-3 and HTR-8/SVneo were solubilized in 8 M urea in 50 mM ammonium bicarbonate, pH 8.5, and reduced with DTT for 1 h. Proteins were then alkylated in 10 mM iodoacetic acid (IAA) for 1 h in the dark. The sample was diluted to 1:10 with 50 mM ammonium bicarbonate and digested with trypsin (20 μg) at 37°C for 18 h. The samples were desalted by solid phase extraction using a STAGE tip protocol (Stop and go extraction tips for matrix-assisted laser desorption/ionization, nano-electrospray, and LC/MS sample pre-treatment in proteomics). The eluted peptides were dried by centrifugal evaporation to remove acetonitrile and redissolved in Solvent A. The resulting peptide mixture was analyzed by liquid chromatography (LC)/mass spectrometry (MS) LC-MS/MS on a 5600 Triple TOF mass spectrometer (AB Sciex, Framingham, USA) equipped with an Eksigent Nanoflow binary gradient HPLC system and a nanospray III ion source. Solvent A was 0.1% formic acid in water and solvent B was 0.1% formic acid in acetonitrile. MS/MS spectra were collected using Information Dependent Acquisition (IDA) using a survey scan (m/z 350--1500) followed by 25 data-dependent product ion scans of the 25 most intense precursor ions. All mass spectra were analyzed using the Mascot and Protein Pilot search engines against the Swissprot-database with the species set as human. Positive identifications were ascribed where Mascot scores were greater than 30. False discovery rate (FDR) was estimated using a reversed sequence database. Finally, proteins identified were submitted to bioinformatic pathway analysis (Ingenuity Pathway Analysis \[IPA\]; Ingenuity Systems, Mountain View, CA; [www.ingenuity.com](http://www.ingenuity.com)).

Statistical analysis
--------------------

Data are represented as mean ± s.e.m. Comparisons between two group means were performed by unpaired Student\'s *t*-tests. Multiple groups were compared using the analysis of variance (ANOVA). *Post-hoc* analyses were used for pairwise comparisons (Bonferroni correction test). Statistical significance was defined as at least *p \< 0.05*. Statistical analyses were preformed using commercially available packages (Stata 11, StatCorp, College Station, TX, USA and Prism 6, GraphPad Inc, La Jolla, CA 92037 USA).

Results {#s3}
=======

Characterization of EVT cell lines
----------------------------------

Figure [1A](#F1){ref-type="fig"} presents photomicrographs of wound closure over 40 h incubation for both cell lines and the percent change in relative wound density over time. The migration rate of HTR-8/SVneo was significantly greater than that observed for JEG-3 cells. Half-maximal stimulatory time (ST~50~) was 31.29 ± 0.14 h and 15.26 ± 0.15 h for JEG-3 and HTR-8SV/neo, respectively (*p* \< 0.05, Figure [1A](#F1){ref-type="fig"}, bottom). Area under curves analysis showed that the migration of HTR-8SV/neo was \~2.0-fold greater than that obtained for JEG-3 cells (Figure [1B](#F1){ref-type="fig"}).

![**Extravillous Trophoblast invasion**. JEG-3 and HTR-8/SVneo cells were grown to confluence in complete media. A wound was made using 96 well WoundMaker and cells were imaged with IncuCyte™ (Essen BioSciences, USA) every 4 h for 40 h (see Materials and Methods). **(A)** Top: Representative images of JEG-3 and HTR-8/SVneo cell migration at 16 h. The gray region denotes the area of the initial wound covered by advancing cells. Bottom: The time course of JEG-3 and HTR-8/SVneo migration. Insert: half-maximal stimulatory time (ST~50~). **(B)** Area under curves analysis from **(A)**. Data represented as mean ± s.e.m. (*n* = 12). In **(B)** ^\*\*\*^*p* \< 0.0001 vs. HTR-8/SVneo.](fphar-05-00175-g0001){#F1}

Characterization of EVT cell line-derived exosomes
--------------------------------------------------

Defining vesicle size range is one of the standard metrics used to confirm that the vesicle preparation in not contaminated with non-exosome vesicles. After differential centrifugation (i.e., 300 × g, 2000 × g, and 12,000 × g), the supernatant was analyzed using a nanoparticles tracking analysis (NTA). Particle size distribution ranged from 30 to 500 nm, with an average of 180 ± 100 nm (Figure [2A](#F2){ref-type="fig"}). Supernatant was filtered and ultracentrifuged to obtain a particulate fraction (including exosomes particles) with a particle size ranged of 30--200 nm (with a mean diameter of 119 ± 65 nm, Figure [2B](#F2){ref-type="fig"}). The exosomes were purified by ultracentrifugation over a sucrose cushion and analyzed using a NTA. The exosome fractions displayed a particle size ranged from 30 to 150 nm in diameter (with mean of 79 ± 68 nm, Figure [2C](#F2){ref-type="fig"}). The presence of exosomal marker CD63 in exosomes isolated from both cell lines was confirmed by Western blot (Figure [2D](#F2){ref-type="fig"}, top). Finally, exosomes isolated from JEG-3 and HTR-8/SVneo were visualized by transmission electron microscopy (Figure [2D](#F2){ref-type="fig"}, bottom). Exosomes were identified as small vesicles between 40 and 100 nm. No significant differences in NTA data, CD63 expression and electron microscopy were identified between cell lines.

![**Characterization of exosome from EVT cells**. Exosomes were isolated from JEG-3 and HTR-8/SV cells by differential and buoyant density centrifugation (see Materials and Methods). **(A--D)** shown representative particles size distribution of exosomes isolation steps from JEG-3 and HTR-8/SV cells. **(A)** After differential centrifugation (i.e., 300 × g, 2000 × g, and 12,000 × g). **(B)** Microsomal fraction prior sucrose density purification. **(C)** After sucrose density purification (30% sucrose cushion). **(D)** Top: representative Western blot for exosome markers: CD63. Bottom: representative electron micrograph exosome fractions, Scale bar 200 nm.](fphar-05-00175-g0002){#F2}

Exosome release from EVT cell lines
-----------------------------------

Exosomal protein release was expressed as total exosomal protein (i.e., particulate material with a buoyant density of 1.127 g/ml) per million cells/24 h. JEG-3 cells released 46 ± 16 ng exosomal protein per million cells per 24 h (*n* = 4; i.e., 4 different isolations from \~200 × 10^6^ cells each) whereas HTR-8/SVneo cells released 120 ± 35 ng exosomal protein per million cells per 24 h (*n* = 4, Figure [3A](#F3){ref-type="fig"}). HTR-8/SVneo cells released significantly more exosomes (\~2.6-folds) in 24 h compared to JEG-3 cells (*p* \< 0.0001). These results were confirmed by quantifying immunoreactive exosomal CD63. The number of exosomes (NEP) released from HTR-8/SVneo cells (6.39 × 10^8^ ± 2.5 × 10^8^/24 h) was \~2.3-fold greater (*p* \< 0.0001) than that observed for JEG-3 cells (2.86 × 10^8^ ± 0.78 × 10^8^/24 h, Figure [3B](#F3){ref-type="fig"}).

![**Exosome releases from EVT cell lines**. Exosomal protein and number of exosomes were quantified cell conditioned media from JEG-3 and HTR-8/SVneo cells using a colorimetric assay and ELISA kit, respectively. **(A)** exosomes concentration presented as μg exosomal protein per 10^6^ cells and **(B)** Number of exosomes particles. Data are presented as scatter dot plot and values are mean ± s.e.m. In **(A,B)** ^\*\*\*^*p* \< 0.001 vs. HTR-8/SVneo.](fphar-05-00175-g0003){#F3}

Effect of EVT-derived exosomes on cell migration
------------------------------------------------

A VSMC was used to establish the effects of EVT-derived exosomes on cell migration. An anti-proliferative drug Mitomycin C (50 and 100 ng/ml) reduces significantly (*p* \< 0.01) VSMC proliferation (Figure [4A](#F4){ref-type="fig"}). A dose of 100 ng/ml decreased VSMC migration compared to 50 ng/ml of Mitomycin C and control (Figure [4B](#F4){ref-type="fig"}). The effects of exosomes (100 μg protein/ml) isolated from JEG-3 and HTR-8/SVneo cultured under 8% O~2~ on VSMC migration under 8% O~2~ are presented in Figures [4C,D](#F4){ref-type="fig"}. All experiments were done in the presence of Mitomycin C (100 ng/ml). The rate of wound closure was significantly increased in the presence of HTR-8/SVneo-derived exosome compared to control (-exosomes) as measured by ST~50~ (15.57 ± 0.32 vs. 25.09 ± 0.58, *p* \< 0.01) (Table [1](#T1){ref-type="table"}). Area under curves analysis showed that HTR-8/SVneo-derived exosome increased \~35 ± 0.2% VSMC migration compared to control. Similarly, exosomes from JEG-3 cells increased VSMC migration \~12 ± 0.1% compared to values in the absence of exosomes (control), however, the effect was smaller compared to exosomes from HTR-8/SVneo. Exosomes were exposed to heat inactivation before incubation on VSMC; however, heat inactivation did not affect the effect of exosomes on VSMC migration. In contrast, sonication completely abolished the HTR-8/SVneo and JEG-3-derived exosomes effect on VSMC migration.

![**EVT-derived exosomes effects on hVSMC migration**. hVSMC were grown to confluence in 231 media and a wound was made using 96 well WoundMaker (see Materials and Methods). hVSMC Migration was measured in absence or presence of 100 ug/ml of exosomes from JEG-3 and HTR-8/SVneo cells and mitomycin C (100 ng/ml) for 48 h. Exosome particles were subjected to sonication (+sonication) or heat inactivation (+heat) before exposure to hVSMC cells **(A,B)** hVSMC proliferation and migration in the presence of Mitomycin C, respectively. **(C)** Time course of wound closure for hVSMC expressed as relative wound density (%). **(D)** Area under curves from data in **(C)**. **(E)** Time-dependent uptake of exosomes using a real time imaging system analysis. Top: images after 24 h; Bottom: Graphical representation of exosome uptake. **(F)** Fluorescent microscopy analysis of exosome uptake (40X). Data represent an *n* = 12 well each point with 3 different cells culture. Values are mean ± SD. In **(D)** ^\*\*\*^*p* \< 0.001 vs. all condition except exo-HTR-8/SVneo + heat; and ^†^*p* \< 0.05 vs. control. In **(E)** ^\*^*p* \< 0.001 vs. corresponding values at 0 h; ^‡^*p* \< 0.05 vs. corresponding values control at 4 h; ^†^*p* \< 0.05 vs. corresponding values control at 8 and 4 h.](fphar-05-00175-g0004){#F4}

###### 

**Kinetic characteristic of exosome effects on hVSMC migration**.

  **Condition**                   **ST~50~ (hours)**
  ------------------------------- ---------------------------------------------
  Control                         25.09±0.58
  +exo-JEG-3                      21.83±0.49[^‡^](#TN3){ref-type="table-fn"}
  +exo-HTR-8/SVneo                15.57±0.32[^\*^](#TN1){ref-type="table-fn"}
  +exo-JEG-3 + sonication         25.06±0.46
  +exo-HTR-8/SVneo + sonication   23.27±0.48
  +exo-JEG-3 + heat               24.14±0.35
  +exo-HTR-8/SVneo + heat         19.43±0.34[^†^](#TN2){ref-type="table-fn"}

*The effect of exosomes isolated from JEG-3 and HTR-8/SVneo-conditioned media on hVSMC in vitro migration. Data are expressed as half-maximal Stimulatory Time (ST~50~ in hours) and represent the mean ± SD*.

*p \< 0.05 vs. control*;

*p \< 0.005 vs. control and +exo-HTR-8/SVneo*.

*p \< 0.005 vs. control*.

The internalization of exosomes labeled with PKH67 (green) in VSMC was quantified and visualized using The IncuCyte and a fluorescence microscope, respectively (Figures [4E,F](#F4){ref-type="fig"}). Exosome uptake by VSMC was observed in a time-dependent manner with the maximum at 24 h (Figure [4E](#F4){ref-type="fig"}, top panel a and c). Sonication abolished the uptake of fluorescent exosomes (Figure [4E](#F4){ref-type="fig"}, top panel b and d) compared to exosomes without sonication. Exosome uptake is presented as fluorescent per cell confluence normalized to maximum uptake of 100%. Heat inactivation did not affect the exosomes uptake by VSMC (Figure [4](#F4){ref-type="fig"}, lower panel). Finally, fluorescence microscope analysis showed an intracellular fluorescent in VSMC cells exposed to intact vesicles from JEG-3 and HTR-8/SVneo (Figure [4F](#F4){ref-type="fig"}).

Proteomic analysis of EVT-derived exosome
-----------------------------------------

Mass spectrometry analysis identified over 140 exosomal proteins, including cell-line specific exosomal proteins (Table [2](#T2){ref-type="table"} and Figure [5A](#F5){ref-type="fig"}). Exosomal proteins isolated from JEG-3 and HTR-8/SVneo cells were associated with cellular movement and morphology, immune cell trafficking and cellular assembly and organization in accordance with Ingenuity Pathway Analysis (IPA) analysis. The canonical pathways associated with our exosomal proteins isolated from JEG-3 and HTR-8/SVneo cells and defined by IPA Core comparison analysis showed that the score (−log \[*p*-value\]) for proteins associated with cell movement and migration was significantly higher (\~1.2-fold, *p* \< 0.05) in HTR-8/SVneo-derived exosomes to compare to exosomes from JEG-3 cells (Figure [5B](#F5){ref-type="fig"}).

###### 

**List of proteins identified in exosomes isolated from JEG-3 and HTR-8/SVneo cells**.

  **Symbol**                                                         **Entrez gene name**                                                                                     **UniProt/Swiss-Prot accession**   **Location**          **Type(s)**
  ------------------------------------------------------------------ -------------------------------------------------------------------------------------------------------- ---------------------------------- --------------------- ----------------------------
  **COMMON PROTEINS IN EXOSOMES FROM JEG-3 and HTR-8/Svneo CELLS**                                                                                                                                                                     
  A2M                                                                Alpha-2-macroglobulin                                                                                    A2MG_HUMAN                         Extracellular space   Transporter
  ACTB                                                               Actin, beta                                                                                              ACTB_HUMAN                         Cytoplasm             Other
  AHSG                                                               Alpha-2-HS-glycoprotein                                                                                  FETUA_HUMAN                        Extracellular space   Other
  ALB                                                                Albumin                                                                                                  ALBU_HUMAN                         Extracellular space   Transporter
  APOE                                                               Apolipoprotein E                                                                                         APOE_HUMAN                         Extracellular space   Transporter
  APOM                                                               Apolipoprotein M                                                                                         APOM_HUMAN                         Plasma membrane       Transporter
  C3                                                                 Complement component 3                                                                                   CO3_HUMAN                          Extracellular space   Peptidase
  EEF2                                                               Eukaryotic translation elongation factor 2                                                               EF2_HUMAN                          Cytoplasm             Translation regulator
  ENO1                                                               Enolase 1, (alpha)                                                                                       ENOA_HUMAN                         Cytoplasm             Enzyme
  F5                                                                 Coagulation factor V (proaccelerin, labile factor)                                                       FA5_HUMAN                          Plasma membrane       Enzyme
  FGB                                                                Fibrinogen beta chain                                                                                    FIBB_HUMAN                         Extracellular space   Other
  FLNA                                                               Filamin A, alpha                                                                                         FLNA_HUMAN                         Cytoplasm             Other
  FN1                                                                Fibronectin 1                                                                                            FINC_HUMAN                         Extracellular space   Enzyme
  HSP90AA1                                                           Heat shock protein 90 kDa alpha (cytosolic), class A member 1                                            HS90A_HUMAN                        Cytoplasm             Enzyme
  HSPA8                                                              Heat shock 70 kDa protein 8                                                                              HSP7C_HUMAN                        Cytoplasm             Enzyme
  KRT1                                                               Keratin 1                                                                                                K2C1_HUMAN                         Cytoplasm             Other
  KRT10                                                              Keratin 10                                                                                               K1C10_HUMAN                        Cytoplasm             Other
  LDHB                                                               Lactate dehydrogenase B                                                                                  LDHB_HUMAN                         Cytoplasm             Enzyme
  MSN                                                                Moesin                                                                                                   MOES_HUMAN                         Plasma membrane       Other
  PGK1                                                               Phosphoglycerate kinase 1                                                                                PGK1_HUMAN                         Cytoplasm             Kinase
  PKM                                                                Pyruvate kinase, muscle                                                                                  KPYM_HUMAN                         Cytoplasm             Kinase
  PZP                                                                Pregnancy-zone protein                                                                                   PZP_HUMAN                          Extracellular space   Other
  THBS1                                                              Thrombospondin 1                                                                                         TSP1_HUMAN                         Extracellular space   Other
  VEPH1                                                              Ventricular zone expressed PH domain-containing 1                                                        MELT_HUMAN                         Nucleus               Other
  YWHAB                                                              Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta                             1433B_HUMAN                        Cytoplasm             Transcription regulator
  YWHAE                                                              Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon                          1433E_HUMAN                        Cytoplasm             Other
  **EXOSOMES FROM JEG-3 CELLS**                                                                                                                                                                                                        
  ACTN1                                                              Actinin, alpha 1                                                                                         ACTN1_HUMAN                        Cytoplasm             Other
  ADAMTS13                                                           ADAM metallopeptidase with thrombospondin type 1 motif, 13                                               ATS13_HUMAN                        Extracellular space   Peptidase
  AFP                                                                Alpha-fetoprotein                                                                                        FETA_HUMAN                         Extracellular space   Transporter
  AHCY                                                               Adenosylhomocysteinase                                                                                   SAHH_HUMAN                         Cytoplasm             Enzyme
  AMY2A                                                              Amylase, alpha 2A (pancreatic)                                                                           AMYP_HUMAN                         Extracellular space   Enzyme
  APOA1                                                              Apolipoprotein A-I                                                                                       APOA1_HUMAN                        Extracellular space   Transporter
  ARGLU1                                                             Arginine and glutamate rich 1                                                                            ARGL1_HUMAN                        Other                 Other
  ATP10A                                                             ATPase, class V, type 10A                                                                                AT10A_HUMAN                        Plasma membrane       Transporter
  C5                                                                 Complement component 5                                                                                   CO5_HUMAN                          Extracellular space   Cytokine
  C7                                                                 Complement component 7                                                                                   CO7_HUMAN                          Extracellular space   Other
  C4A/C4B                                                            Complement component 4B (Chido blood group)                                                              CO4A_HUMAN                         Extracellular space   Other
  C8B                                                                Complement component 8, beta polypeptide                                                                 CO8B_HUMAN                         Extracellular space   Other
  CLEC11A                                                            C-type lectin domain family 11, member A                                                                 CLC11_HUMAN                        Extracellular space   Growth factor
  COL6A1                                                             Collagen, type VI, alpha 1                                                                               CO6A1_HUMAN                        Extracellular space   Other
  COLGALT1                                                           Collagen beta(1-O)galactosyltransferase 1                                                                GT251_HUMAN                        Cytoplasm             Other
  COMP                                                               Cartilage oligomeric matrix protein                                                                      COMP_HUMAN                         Extracellular space   Other
  CPN1                                                               Carboxypeptidase N, polypeptide 1                                                                        CBPN_HUMAN                         Extracellular space   Peptidase
  DGKQ                                                               Diacylglycerol kinase, theta 110 kDa                                                                     DGKQ_HUMAN                         Cytoplasm             Kinase
  EEF1A2                                                             Eukaryotic translation elongation factor 1 alpha 2                                                       EF1A2_HUMAN                        Cytoplasm             Translation regulator
  F2                                                                 Coagulation factor II (thrombin)                                                                         THRB_HUMAN                         Extracellular space   Peptidase
  F10                                                                Coagulation factor X                                                                                     FA10_HUMAN                         Extracellular space   Peptidase
  F13A1                                                              Coagulation factor XIII, A1 polypeptide                                                                  F13A_HUMAN                         Extracellular space   Enzyme
  FBLN1                                                              Fibulin 1                                                                                                FBLN1_HUMAN                        Extracellular space   Other
  FGG                                                                Fibrinogen gamma chain                                                                                   FIBG_HUMAN                         Extracellular space   Other
  GC                                                                 Group-specific component (vitamin D binding protein)                                                     VTDB_HUMAN                         Extracellular space   Transporter
  GSN                                                                Gelsolin                                                                                                 GELS_HUMAN                         Extracellular space   Other
  H2AFV                                                              H2A histone family, member V                                                                             H2AV_HUMAN                         Nucleus               Other
  HBB                                                                Hemoglobin, beta                                                                                         HBB_HUMAN                          Cytoplasm             Transporter
  HIST1H1T                                                           Histone cluster 1, H1t                                                                                   H1T_HUMAN                          Nucleus               Other
  HIST1H2BB                                                          Histone cluster 1, H2bb                                                                                  H2B1B_HUMAN                        Nucleus               Other
  HSPA1L                                                             Heat shock 70kDa protein 1-like                                                                          HS71L_HUMAN                        Other                 Other
  IGLL1/IGLL5                                                        Immunoglobulin lambda-like polypeptide 1                                                                 IGLL5_HUMAN                        Plasma membrane       Other
  ITIH1                                                              Inter-alpha-trypsin inhibitor heavy chain 1                                                              ITIH1_HUMAN                        Extracellular space   Other
  ITIH2                                                              Inter-alpha-trypsin inhibitor heavy chain 2                                                              ITIH2_HUMAN                        Extracellular space   Other
  ITIH3                                                              Inter-alpha-trypsin inhibitor heavy chain 3                                                              ITIH3_HUMAN                        Extracellular space   Other
  LINC00083                                                          Long intergenic non-protein coding RNA 83                                                                YA021_HUMAN                        Other                 Other
  LRP1                                                               Low density lipoprotein receptor-related protein 1                                                       LRP1_HUMAN                         Plasma membrane       Transmembrane receptor
  LUM                                                                Lumican                                                                                                  LUM_HUMAN                          Extracellular space   Other
  MYH9                                                               Myosin, heavy chain 9, non-muscle                                                                        MYH9_HUMAN                         Cytoplasm             Transporter
  MYL6                                                               Myosin, light chain 6, alkali, smooth muscle and non-muscle                                              MYL6_HUMAN                         Cytoplasm             Other
  NHSL2                                                              NHS-like 2                                                                                               NHSL2_HUMAN                        Other                 Other
  OR2W3                                                              Olfactory receptor, family 2, subfamily W, member 3                                                      OR2W3_HUMAN                        Plasma membrane       G-protein coupled receptor
  PIF1                                                               PIF1 5′-to-3′ DNA helicase                                                                               PIF1_HUMAN                         Nucleus               Enzyme
  PITRM1                                                             Pitrilysin metallopeptidase 1                                                                            PREP_HUMAN                         Cytoplasm             Peptidase
  PLG                                                                Plasminogen                                                                                              PLMN_HUMAN                         Extracellular space   Peptidase
  PPP6R3                                                             Protein phosphatase 6, regulatory subunit 3                                                              PP6R3_HUMAN                        Cytoplasm             Other
  RAN                                                                RAN, member RAS oncogene family                                                                          RAN_HUMAN                          Nucleus               Enzyme
  RDH13                                                              Retinol dehydrogenase 13 (all-trans/9-cis)                                                               RDH13_HUMAN                        Cytoplasm             Enzyme
  SERPINA7                                                           Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 7                      THBG_HUMAN                         Extracellular space   Transporter
  SERPINF1                                                           Serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1   PEDF_HUMAN                         Extracellular space   Other
  SERPINF2                                                           Serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2   A2AP_HUMAN                         Extracellular space   Other
  THBS4                                                              Thrombospondin 4                                                                                         TSP4_HUMAN                         Extracellular space   Other
  TLN1                                                               Talin 1                                                                                                  TLN1_HUMAN                         Plasma membrane       Other
  TUBA1B                                                             Tubulin, alpha 1b                                                                                        TBA1B_HUMAN                        Cytoplasm             Other
  TUBA4A                                                             Tubulin, alpha 4a                                                                                        TBA4A_HUMAN                        Cytoplasm             Other
  VTN                                                                Vitronectin                                                                                              VTNC_HUMAN                         Extracellular space   Other
  YWHAZ                                                              Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta                             1433Z_HUMAN                        Cytoplasm             Enzyme
  ZNF480                                                             Zinc finger protein 480                                                                                  ZN480_HUMAN                        Nucleus               Other
  **EXOSOMES FROM HTR-8/SVneo CELLS**                                                                                                                                                                                                  
  AASDH                                                              Aminoadipate-semialdehyde dehydrogenase                                                                  ACSF4_HUMAN                        Other                 Enzyme
  ACTN4                                                              Actinin, alpha 4                                                                                         ACTN4_HUMAN                        Cytoplasm             Other
  ALDOA                                                              Aldolase A, fructose-bisphosphate                                                                        ALDOA_HUMAN                        Cytoplasm             Enzyme
  ANXA2                                                              Annexin A2                                                                                               ANXA2_HUMAN                        Plasma membrane       Other
  ANXA5                                                              Annexin A5                                                                                               ANXA5_HUMAN                        Plasma membrane       Other
  ANXA6                                                              Annexin A6                                                                                               ANXA6_HUMAN                        Plasma membrane       Other
  APOB                                                               Apolipoprotein B                                                                                         APOB_HUMAN                         Extracellular space   Transporter
  ARAP2                                                              ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2                                                ARAP2_HUMAN                        Cytoplasm             Other
  ART4                                                               ADP-ribosyltransferase 4 (Dombrock blood group)                                                          NAR4_HUMAN                         Nucleus               Enzyme
  ATP1A1                                                             ATPase, Na^+^/K^+^ transporting, alpha 1 polypeptide                                                     AT1A1_HUMAN                        Plasma membrane       Transporter
  B2M                                                                Beta-2-microglobulin                                                                                     B2MG_HUMAN                         Plasma membrane       Transmembrane receptor
  BASP1                                                              Brain abundant, membrane attached signal protein 1                                                       BASP1_HUMAN                        Nucleus               Transcription regulator
  BMS1                                                               BMS1 ribosome biogenesis factor                                                                          BMS1_HUMAN                         Nucleus               Other
  C9                                                                 Complement component 9                                                                                   CO9_HUMAN                          Extracellular space   Other
  C7orf61                                                            Chromosome 7 open reading frame 61                                                                       CG061_HUMAN                        Other                 Other
  CD59                                                               CD59 molecule, complement regulatory protein                                                             CD59_HUMAN                         Plasma membrane       Other
  CHM                                                                Choroideremia (Rab escort protein 1)                                                                     RAE1_HUMAN                         Cytoplasm             Enzyme
  CLTC                                                               Clathrin, heavy chain (Hc)                                                                               CLH1_HUMAN                         Plasma membrane       Other
  COL12A1                                                            Collagen, type XII, alpha 1                                                                              COCA1_HUMAN                        Extracellular space   Other
  FLNB                                                               Filamin B, beta                                                                                          FLNB_HUMAN                         Cytoplasm             Other
  FSCN1                                                              Fascin homolog 1, actin-bundling protein (Strongylocentrotus purpuratus)                                 FSCN1_HUMAN                        Cytoplasm             Other
  GAPDH                                                              Glyceraldehyde-3-phosphate dehydrogenase                                                                 G3P_HUMAN                          Cytoplasm             Enzyme
  GLP2R                                                              Glucagon-like peptide 2 receptor                                                                         GLP2R_HUMAN                        Plasma membrane       G-protein coupled receptor
  GNAI2                                                              Guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2                  GNAI2_HUMAN                        Plasma membrane       Enzyme
  GNB1                                                               Guanine nucleotide binding protein (G protein), beta polypeptide 1                                       GBB1_HUMAN                         Plasma membrane       Enzyme
  GNG12                                                              Guanine nucleotide binding protein (G protein), gamma 12                                                 GBG12_HUMAN                        Plasma membrane       Enzyme
  HBD                                                                Hemoglobin, delta                                                                                        HBD_HUMAN                          Other                 Transporter
  HIST1H1D                                                           Histone cluster 1, H1d                                                                                   H13_HUMAN                          Nucleus               Other
  HIST1H2BD                                                          Histone cluster 1, H2bd                                                                                  H2B1D_HUMAN                        Nucleus               Other
  HMCN1                                                              Hemicentin 1                                                                                             HMCN1_HUMAN                        Extracellular space   Other
  HSP90AB1                                                           Heat shock protein 90 kDa alpha (cytosolic), class B member 1                                            HS90B_HUMAN                        Cytoplasm             Enzyme
  HSPB1                                                              Heat shock 27 kDa protein 1                                                                              HSPB1_HUMAN                        Cytoplasm             Other
  HSPE1                                                              Heat shock 10 kDa protein 1                                                                              CH10_HUMAN                         Cytoplasm             Enzyme
  ITGA3                                                              integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor)                                     ITA3_HUMAN                         Plasma membrane       Other
  ITGB1                                                              Integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)             ITB1_HUMAN                         Plasma membrane       Transmembrane receptor
  KRT9                                                               Keratin 9                                                                                                K1C9_HUMAN                         Cytoplasm             Other
  LGALS1                                                             Lectin, galactoside-binding, soluble, 1                                                                  LEG1_HUMAN                         Extracellular space   Other
  MFGE8                                                              Milk fat globule-EGF factor 8 protein                                                                    MFGM_HUMAN                         Extracellular space   Other
  MIF                                                                Macrophage migration inhibitory factor (glycosylation-inhibiting factor)                                 MIF_HUMAN                          Extracellular space   Cytokine
  NCL                                                                Nucleolin                                                                                                NUCL_HUMAN                         Nucleus               Other
  NME2                                                               NME/NM23 nucleoside diphosphate kinase 2                                                                 NDKB_HUMAN                         Nucleus               Kinase
  NRG1                                                               Neuregulin 1                                                                                             NRG1_HUMAN                         Other                 Growth factor
  PARK7                                                              Parkinson protein 7                                                                                      PARK7_HUMAN                        Nucleus               Enzyme
  PGAM1                                                              Phosphoglycerate mutase 1 (brain)                                                                        PGAM1_HUMAN                        Cytoplasm             Phosphatase
  PRDX1                                                              Peroxiredoxin 1                                                                                          PRDX1_HUMAN                        Cytoplasm             Enzyme
  PTGFRN                                                             Prostaglandin F2 receptor inhibitor                                                                      FPRP_HUMAN                         Plasma membrane       Other
  RUVBL2                                                             RuvB-like AAA ATPase 2                                                                                   RUVB2_HUMAN                        Nucleus               transcription regulator
  S100A11                                                            S100 calcium binding protein A11                                                                         S10AB_HUMAN                        Cytoplasm             Other
  SERPINA1                                                           Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1                      A1AT_HUMAN                         Extracellular space   Other
  SLC16A3                                                            Solute carrier family 16 (monocarboxylate transporter), member 3                                         MOT4_HUMAN                         Plasma membrane       Transporter
  SLC2A1                                                             Solute carrier family 2 (facilitated glucose transporter), member 1                                      GTR1_HUMAN                         Plasma membrane       Transporter
  STARD13                                                            StAR-related lipid transfer (START) domain containing 13                                                 STA13_HUMAN                        Cytoplasm             Other
  SYN1                                                               Synapsin I                                                                                               SYN1_HUMAN                         Plasma membrane       Transporter
  TMEM262                                                            Transmembrane protein 262                                                                                YK025_HUMAN                        Other                 Other
  TPI1                                                               Triosephosphate isomerase 1                                                                              TPIS_HUMAN                         Cytoplasm             Enzyme
  TRRAP                                                              Transformation/transcription domain-associated protein                                                   TRRAP_HUMAN                        Nucleus               Transcription regulator
  TUBBP5                                                             Tubulin, beta pseudogene 5                                                                               YI016_HUMAN                        Other                 Other
  UBAC2                                                              UBA domain containing 2                                                                                  UBAC2_HUMAN                        Cytoplasm             Enzyme
  VIM                                                                Vimentin                                                                                                 VIME_HUMAN                         Cytoplasm             Other

*All mass spectra were analyzed using the Mascot and Protein Pilot search engines against the Swissprot-swissprot database with the species set as human (score over 30). Exosomal proteins identified by mass-spectrometry were analyzed with the Ingenuity Pathway Analysis (Ingenuity Systems, [www.ingenuity.com](http://www.ingenuity.com)). False discovery rate (FDR) was estimated using a reversed sequence database. List of total exosomal protein from cytotrophoblast cells exposed to different oxygen level are presented as Protein ID, Symbol, Entrez Gene Name, Location, and type*.

![**Analysis of EVT cell-derived exosomes proteins. (A)** The Venn diagram represents the distribution of common and unique proteins identified by nanospray LC-MS/MS (ABSciex 5600) in exosomes released from JEG-3 and HTR-8/SVneo cells. **(B)** Comparison of biological function (cell movement and migration) identified by IPA core analysis. In **(B)** values are mean ± s.e.m. In **(B)** ^\*^*p* \< 0.05 vs. HTR-8/SVneo cells.](fphar-05-00175-g0005){#F5}

Discussion {#s4}
==========

A tenet of contemporary obstetrics is that events that compromise placentation and the development of the materno-fetal exchange increase the risk of complications of pregnancy and contribute to poor pregnancy outcome. In particular, conditions that affect the differentiation and invasion of placental cells compromise placental perfusion and function (Jauniaux et al., [@B14], [@B15]; Burton et al., [@B7]) and the subsequent growth and development of the fetus (Khong et al., [@B17]). EVT migrate into maternal decidua and myometrium and interact with VSMC in uterine spiral arteries. Conversion of these arteries is associated with the loss of VSMC from the vessel wall by migration out of the vessel. In this study we established that: (1) exosome isolated from EVT-like cell lines (JEG-3 and HTR-8/SVneo) with different cellular origins (choriocarcinoma and EVT) exhibit differences in their rate of release, protein content and bioactivity; and (2) both exosomes from JEG-3 and HTR-8/SVneo cells increase VSMC migration. However, the effect of exosomes from HTR-8/SVneo was significantly higher. Exosomes released from first trimester trophoblast cells (EVT), therefore, may regulate processes that play a key role in placentation and remodeling of the uterine spiral arteries.

The interactions between EVT and VSMC are not fully understood, in part due to difficulties of accessing first trimester samples and the lack of suitable animal models (Carter, [@B8]; Ackerman et al., [@B2]). We obtained nanovesicles with high purity. The data presented establish that the final preparation used display a size distribution and buoyant consistent with exosomes and the lack of significant contamination by microsomes. In this study, we quantified the release of exosomes from JEG-3 and HTR-8/SVneo cells (as indicated by immunoreactive exosomal CD63). The data obtained establish that exosome release is cell type specific and correlated with cell migration capacity. Consistent with these data, a correlation between exosome release and cell invasiveness has been described previously in ovarian cancer cells (Kobayashi et al., [@B19]).

The initial stages of uterine SpA remodeling involves a loss of the VSMC component by apoptosis, migration or a combination of both processes. In this study, we identify a novel exosomal signaling pathway by which EVT (HTR-8/SVneo cells) promote the migration of VSMC. Consistent with these data, Bulmer et al. ([@B6]) observed that VSMC migration plays a major role in remodeling of the artery by migration into the decidua and vessel lumen and this phenomenon is enhanced in the presence of EVT cells (Bulmer et al., [@B6]). Based upon the available data, we propose that perivascular EVT release exosomes that interaction with VSMC and promote their migration out of SpAs and alter the vasoreactive of these vessels. This effect of exosomes on VSMC migration was cell-type specific (i.e., only exosomes from HTR-8/SVneo cells promote cell migration) and may reflect the different cellular origin of the two cell lines compared in this study. HTR-8/SVneo cells are derived by transfection of first trimester trophoblast cells (Graham et al., [@B12]). JEG-3 cells are derived from a choriocarcinoma (Kohler and Bridson, [@B20]). Difference in the molecular cargo carried by exosomes released from HTR-8/SVneo and JEG-3 cell may account for their different effects on target cell migration. Consistent with this suggestion, proteins involved in cell migration were differentially represented in exosomes isolated from the two-cell lines.

The exosomal content is highly dependent on the cell origin and on pre-conditioning of the cell. Exosomes function as a carrier of specific molecules such as, proteins, lipids, mRNA, and miRNA and can interact with neighboring cells or travel long distances in the bloodstream to reprogram the phenotype and regulate their function (Denzer et al., [@B11]). In this study, we identified unique proteins (58 and 59 proteins in exosome from JEG-3 and HTR-8/SVneo cells) and common proteins (26) between these EVT cell lines. Ingenuity Pathway Analysis (IPA) of exosomal proteins identified cell-dependent changes in cell movement and migration signaling pathways. Exosomes have been reported to express a diverse range of cell surface receptors, proteins (including, heat shock proteins, cytoskeletal proteins, adhesion molecules, membrane transport, and fusion proteins), mRNA and miRNA with the potential to affect the acute and long-term function of the cells with which they interact (Ambros, [@B3]). Recent data demonstrate that trophoblast-derived exosomes induce proinflammatory cytokines such IL-1 β in human macrophages cells (Atay et al., [@B4]). Furthermore, *in vitro* exposure of PBMC and dendritic cells to exosomal proteins induce differentiation of stem cells; suppression of activation of natural killer cells and macrophages; and stimulation of cell migration (Mincheva-Nilsson et al., [@B22]; Knight, [@B18]; Soo et al., [@B31]). Interestingly, protein analysis revealed that exosome release from cytrophoblast cells increases with low oxygen tension and their exosome promotes cell migration in extravillous cytotrophoblast (HTR-8/SVneo) (Salomon et al., [@B29]).

The observed effects of HTR-8/SVneo-derived exosomes on VSCM migration were also dependent upon exosome structural integrity. Disruption of exosomes by sonication (Delorme-Axford et al., [@B10]) completely abolished their effect on VSMC migration. While the precise mechanisms by which sonication abolishes the effects of exosomes remains to be established, preventing exosomal fusion with VSMC cell membrane and the intracellular delivery of signaling molecules and/or the loss of capacity to appropriately present exosomal surface moieties to target cell receptors represent possible pathways and warrant further investigation. We establish in this study that exosome integrity is critical to mediating their effects on VSMC migration. It is not possible from the data obtained in this study to differentiate between sonication--induced disruption of exosome: uptake; fusion; activation of VSMC cell surface receptors, or a combination of these (and other) mechanisms. The elucidation of contribution of these mechanisms will require additional extensive studies to establish.

In conclusion, using *in vitro* EVT-like cell lines, we have demonstrated difference in release, composition and bioactivity between exosomes from JEG-3 and HTR-8/SVneo cells. Exosomes released from EVT may play a role in remodeling SpA by promoting migration of VSMC. Exosomal-induced VSCM migration is associated with increased representation of proteins involved in cell migration processes within their molecular cargo and dependent upon exosomal structural integrity. The identification of this EVT-VSMC exosomal communication pathway not only affords opportunity for developing biomarkers of placentation but also the assessment of exosome targeted therapeutic innervation strategies.
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